BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29150407)

  • 1. Disease trends over time and CD4
    Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus.
    McMahon M; Skaggs BJ; Grossman JM; Sahakian L; Fitzgerald J; Wong WK; Lourenco EV; Ragavendra N; Charles-Schoeman C; Gorn A; Karpouzas GA; Taylor MB; Watson KE; Weisman MH; Wallace DJ; Hahn BH
    Arthritis Rheumatol; 2014 Jan; 66(1):130-9. PubMed ID: 24449580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity.
    Al-Saleh J; el-Eissawy S
    Egypt J Immunol; 2006; 13(2):41-8. PubMed ID: 18689270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study.
    Jung JY; Kim HA; Lee HY; Suh CH
    Int J Rheum Dis; 2019 Aug; 22(8):1410-1418. PubMed ID: 31050219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
    Ammirati E; Bozzolo EP; Contri R; Baragetti A; Palini AG; Cianflone D; Banfi M; Uboldi P; Bottoni G; Scotti I; Pirillo A; Grigore L; Garlaschelli K; Monaco C; Catapano AL; Sabbadini MG; Manfredi AA; Norata GD
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):751-9. PubMed ID: 24787906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
    Maksimowicz-McKinnon K; Magder LS; Petri M
    J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
    Roman MJ; Crow MK; Lockshin MD; Devereux RB; Paget SA; Sammaritano L; Levine DM; Davis A; Salmon JE
    Arthritis Rheum; 2007 Oct; 56(10):3412-9. PubMed ID: 17907140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.
    Clancy R; El Bannoudi H; Rasmussen SE; Bornkamp N; Allen N; Dann R; Reynolds H; Buyon JP; Berger JS
    J Thromb Haemost; 2019 Mar; 17(3):532-537. PubMed ID: 30638300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.
    Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2018 Dec; 57(12):2158-2166. PubMed ID: 30102390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of circulating CXCR3
    Han L; Yang X; Yu Y; Wan W; Lv L; Zou H
    Mod Rheumatol; 2019 May; 29(3):461-469. PubMed ID: 29694256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody profiling reveals four protein candidate autoantigens associated with systemic lupus erythematosus.
    Frostegård J; Hellström C; Nilsson P; Frostegård AG; Ajeganova S
    Lupus; 2018 Sep; 27(10):1670-1678. PubMed ID: 30041579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.
    Papazoglou N; Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG
    Rheumatology (Oxford); 2024 Jan; 63(1):50-57. PubMed ID: 37086440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.
    Kiani AN; Fang H; Akhter E; Quiroga C; Simpson N; Alaupovic P; Magder LS; Petri M
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):442-6. PubMed ID: 25155365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value.
    Hammad SM; Harden OC; Wilson DA; Twal WO; Nietert PJ; Oates JC
    Front Immunol; 2021; 12():694318. PubMed ID: 34367153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.
    Kiani AN; Post WS; Magder LS; Petri M
    Rheumatology (Oxford); 2011 Nov; 50(11):2071-9. PubMed ID: 21875880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.